A detailed history of Thrivent Financial For Lutherans transactions in Avanos Medical, Inc. stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 36,084 shares of AVNS stock, worth $671,162. This represents 0.0% of its overall portfolio holdings.

Number of Shares
36,084
Previous 38,107 5.31%
Holding current value
$671,162
Previous $759,000 14.23%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$19.21 - $24.69 $38,861 - $49,947
-2,023 Reduced 5.31%
36,084 $867,000
Q2 2024

Aug 13, 2024

SELL
$17.85 - $20.42 $38,698 - $44,270
-2,168 Reduced 5.38%
38,107 $759,000
Q1 2024

May 14, 2024

SELL
$17.97 - $22.68 $127,640 - $161,096
-7,103 Reduced 14.99%
40,275 $802,000
Q4 2023

Feb 14, 2024

SELL
$17.64 - $22.99 $483,265 - $629,834
-27,396 Reduced 36.64%
47,378 $1.06 Million
Q3 2023

Nov 14, 2023

SELL
$19.93 - $26.31 $35,156 - $46,410
-1,764 Reduced 2.3%
74,774 $1.51 Million
Q2 2023

Aug 14, 2023

SELL
$22.53 - $30.98 $67,657 - $93,032
-3,003 Reduced 3.78%
76,538 $1.96 Million
Q1 2023

May 17, 2023

SELL
$26.92 - $31.75 $43,475 - $51,276
-1,615 Reduced 1.99%
79,541 $2.37 Million
Q4 2022

Feb 08, 2023

SELL
$19.88 - $27.37 $1.25 Million - $1.73 Million
-63,079 Reduced 43.73%
81,156 $2.2 Million
Q3 2022

Nov 14, 2022

SELL
$21.56 - $29.59 $1.5 Million - $2.06 Million
-69,552 Reduced 32.53%
144,235 $3.14 Million
Q2 2022

Aug 16, 2022

BUY
$24.87 - $34.68 $2.84 Million - $3.97 Million
114,379 Added 115.06%
213,787 $5.85 Million
Q1 2022

May 13, 2022

BUY
$28.87 - $35.77 $1.74 Million - $2.15 Million
60,193 Added 153.49%
99,408 $3.33 Million
Q4 2021

Feb 16, 2022

BUY
$29.25 - $36.02 $9,272 - $11,418
317 Added 0.81%
39,215 $1.36 Million
Q3 2021

Nov 15, 2021

SELL
$31.2 - $38.5 $12,511 - $15,438
-401 Reduced 1.02%
38,898 $1.21 Million
Q2 2021

Aug 19, 2021

BUY
$36.37 - $45.72 $965,550 - $1.21 Million
26,548 Added 208.2%
39,299 $1.43 Million
Q1 2021

May 17, 2021

BUY
$43.5 - $53.4 $9,918 - $12,175
228 Added 1.82%
12,751 $558,000
Q4 2020

Feb 16, 2021

SELL
$33.15 - $49.5 $11,934 - $17,820
-360 Reduced 2.79%
12,523 $575,000
Q3 2020

Nov 10, 2020

SELL
$28.67 - $34.32 $8,859 - $10,604
-309 Reduced 2.34%
12,883 $428,000
Q2 2020

Aug 12, 2020

BUY
$23.48 - $33.86 $15,684 - $22,618
668 Added 5.33%
13,192 $388,000
Q4 2019

Feb 13, 2020

BUY
$31.89 - $47.34 $4,368 - $6,485
137 Added 1.11%
12,524 $422,000
Q3 2019

Nov 14, 2019

SELL
$32.06 - $44.0 $5,065 - $6,952
-158 Reduced 1.26%
12,387 $464,000
Q2 2019

Aug 13, 2019

BUY
$37.68 - $46.52 $9,759 - $12,048
259 Added 2.11%
12,545 $547,000
Q1 2019

May 14, 2019

BUY
$39.84 - $51.04 $10,956 - $14,036
275 Added 2.29%
12,286 $524,000
Q4 2018

Feb 15, 2019

BUY
$41.16 - $66.67 $27,371 - $44,335
665 Added 5.86%
12,011 $538,000
Q3 2018

Nov 15, 2018

BUY
$55.13 - $72.65 $625,504 - $824,286
11,346 New
11,346 $777,000

Others Institutions Holding AVNS

About AVANOS MEDICAL, INC.


  • Ticker AVNS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 46,487,000
  • Market Cap $865M
  • Description
  • Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...
More about AVNS
Track This Portfolio

Track Thrivent Financial For Lutherans Portfolio

Follow Thrivent Financial For Lutherans and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.